US Patent 11427623 Methods of treatment using mutant FGF-21 peptide conjugates
All edits
Edits on 26 Apr, 2023
Golden AI
Infobox
Edits on 5 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
114276230
Date of Patent
August 30, 2022
0Patent Application Number
168853530
Date Filed
May 28, 2020
0Patent Citations
Patent Primary Examiner
CPC Code
Edits on 22 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
114276230
Date of Patent
August 30, 2022
0Patent Application Number
168853530
Date Filed
May 28, 2020
0Patent Citations
Patent Primary Examiner
CPC Code
Edits on 25 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 31 Aug, 2022
Golden AI
Edits made to:
Infobox (+11 properties)
Article (+270 characters)
US Patent 11427623 Methods of treatment using mutant FGF-21 peptide conjugates
Article
Therapeutic regimens and uses of mutant Fibroblast Growth Factor-21 (FGF-21) peptide conjugates comprising a polyethylene glycol (PEG) moiety attached to a mutant FGF-21 peptide via a glycosyl moiety thereof in the treatment of nonalcoholic steatohepatitis are provided.
Infobox
Is a
Patent Jurisdiction
Patent Number
11427623
Date of Patent
August 30, 2022
Patent Application Number
16885353
Date Filed
May 28, 2020
Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11427623 Methods of treatment using mutant FGF-21 peptide conjugates
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
